Abstract

Material & Methods: This was a randomized clinical trial study in the Pediatric Clinic of Amir Kabir Hospital in Arak, Iran. A total of 110 infants were randomized into 2 treatment groups who received either brewed black tea add ophthalmic erythromycin ointment 1% with sulfastamid drop 10% (group A)TDS or just antibiotics (group B) for 7 days. In group A, before used of antibiotics sticky eyelids were wiped with sterile cotton of brewed black tea and in control group just antibiotics were applied. Severity of conjunctivitis at first, 3th and 7th days during treatment and duration of disease were determined. Results: At first day of prescribing strategies, group A severity of infants' conjunctivitis were mild in12/7 %( 7), moderate 32/7 %( 18) and sever 54/5 %( 30). In just antibiotics were 18/2 %( 10), 30/9%(17), 50/9 %( 28) respectively. Difference wasn't significant. At 3rd day, in group A 74/5 %( 41) of infants were cured, in 25/5%( 14), severity were mild. In control group, 9/1 %( 5) cured, mild were 21/8 (12), moderate 47/3 %( 26) and sever 21/8 %( 12). Differences was significant (P=0/001). At 7th days, in group A 100 %( 55), in just antibiotics 34/5 %( 19) were cured. Mild severity of conjunctivitis were 45/5 %( 25) and moderate were 20 %( 11), in control group. Conclusion: Brewed black tea adds antibiotics reduced severity of infants' conjunctivitis and duration of treatment. It seems it is safe; effectiveness, accessible and cost benefit for adjust treatment of this disease.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.